Unlike these publications, in our study, we found that the levels of p53 autoantibodies were high both in skin BCC and SCC (P < 0.001), and data from Oncomine showed that the p53 mRNA level was significantly higher in BCC than in normal skin (P < 0.05). The gene discussed is TP53; the disease is skin basal cell carcinoma.